Gene · 1829
Papers2,548
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,548
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Left-dominant arrhythmogenic cardiomyopathy due to desmoplakin mutation: a case report. | ESC Heart Fail | 2023 | 37632291 | PubTator, text mining | PubMed |
| Store-Operated Ca2+ Entry as a Putative Target of Flecainide for the Treatment of Arrhythmogenic Cardiomyopathy. | J Clin Med | 2023 | 37629337 | PubTator, text mining | PubMed |
| Uncovering Novel Roles of miR-122 in the Pathophysiology of the Liver: Potential Interaction with NRF1 and E2F4 Signaling. | Cancers (Basel) | 2023 | 37627157 | PubTator, text mining | PubMed |
| Whole genomic analysis reveals atypical non-homologous off-target large structural variants induced by CRISPR-Cas9-mediated genome editing. | Nat Commun | 2023 | 37626063 | PubTator, text mining | PubMed |
| From gene-discovery to gene-tailored clinical management: 25 years of research in channelopathies and cardiomyopathies. | Europace | 2023 | 37622577 | PubTator, text mining | PubMed |
| 25 years of basic and translational science in EP Europace: novel insights into arrhythmia mechanisms and therapeutic strategies. | Europace | 2023 | 37622575 | PubTator, text mining | PubMed |
| Desmocollin-1 is associated with pro-metastatic phenotype of luminal A breast cancer cells and is modulated by parthenolide. | Cell Mol Biol Lett | 2023 | 37620794 | PubTator, text mining | PubMed |
| Refining a Multifaceted Model of Perceived Utility of Genomic Sequencing Results. | Public Health Genomics | 2023 | 37607497 | PubTator, text mining | PubMed |
| Biallelic truncating variants in children with titinopathy represent a recognizable condition with distinctive muscular and cardiac characteristics: a report on five patients. | Front Cardiovasc Med | 2023 | 37576110 | PubTator, text mining | PubMed |
| Novel Mutation Glu98Lys in Cardiac Tropomyosin Alters Its Structure and Impairs Myocardial Relaxation. | Int J Mol Sci | 2023 | 37569730 | PubTator, text mining | PubMed |
| Nomogram for predicting cardiac death and heart transplantation in arrhythmogenic right ventricular cardiomyopathy. | ESC Heart Fail | 2023 | 37563882 | PubTator, text mining | PubMed |
| Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease. | JCI Insight | 2023 | 37561594 | PubTator, text mining | PubMed |
| Pathogenicity and virulence of human adenovirus F41: Possible links to severe hepatitis in children. | Virulence | 2023 | 37543996 | PubTator, text mining | PubMed |
| Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex. | J Biol Chem | 2023 | 37536630 | PubTator, text mining | PubMed |
| Rare Cutaneous Side Effects of Imiquimod: A Review on Its Mechanisms, Diagnosis, and Management. | Dermatol Ther (Heidelb) | 2023 | 37528289 | PubTator, text mining | PubMed |
| Recommendations for the Management of Cardiomyopathy Mutation Carriers: Evidence, Doubts, and Intentions. | J Clin Med | 2023 | 37510821 | PubTator, text mining | PubMed |
| The Novel Variant NP_00454563.2 (p.Glu259Glyfs*77) in Gene PKP2 Associated with Arrhythmogenic Cardiomyopathy in 8 Families from Malaga, Spain. | Genes (Basel) | 2023 | 37510372 | PubTator, text mining | PubMed |
| Desmosomal Arrhythmogenic Cardiomyopathy: The Story Telling of a Genetically Determined Heart Muscle Disease. | Biomedicines | 2023 | 37509658 | PubTator, text mining | PubMed |
| Clinically actionable secondary findings in 130 triads from sub-Saharan African families with non-syndromic orofacial clefts. | Mol Genet Genomic Med | 2023 | 37496383 | PubTator, text mining | PubMed |
| Cutaneous squamous cell carcinoma-derived extracellular vesicles exert an oncogenic role by activating cancer-associated fibroblasts. | Cell Death Discov | 2023 | 37495566 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1829/papers?page=14